The global mannitol market is projected to grow from USD 543.0 million in 2026 to USD 1,048.3 million by 2036, registering a 6.8% CAGR during the forecast period. Demand is supported by mannitol’s multifunctional role in food and pharmaceutical applications, including sweetness, low moisture uptake, flow control, anticaking performance, and solid-dose functionality. The market is also benefiting from demand for specification-driven pharmaceutical excipients and food-grade ingredients.
Mannitol’s use across food formulations and pharmaceutical excipients creates opportunities for manufacturers offering consistent physical properties and application-specific grades. In pharmaceutical applications, low hygroscopicity, particle engineering, direct-compression performance, and quality documentation are important purchasing considerations. Food manufacturers also use mannitol for sweetening, bulking, anticaking, and moisture-management functions, although application-specific regulatory requirements continue to influence formulation decisions.
Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-13245
Global Segment Leaders
- Form – Crystal: 63.1% in 2026. Crystal mannitol leads because crystalline grades fit established food handling and pharmaceutical excipient workflows, including dusting, bulking, blending, filling, and solid-dose formulation.
- End Use – Food: 26.2% in 2026. Food applications benefit from mannitol’s combination of sweetness, bulking, anticaking, low hygroscopicity, and moisture-management properties across permitted formulations.
Country-Level Performance
South Korea is projected to record the fastest growth among the profiled countries, with an 8.7% CAGR through 2036. The country’s current food-additive framework and active import activity support demand for mannitol supplied with appropriate specifications, certificates, and traceability documentation.
The United Kingdom is forecast to expand at an 8.1% CAGR. E421 remains an authorized sweetener, while food-specific quantitative limits make formulation guidance and regulatory compliance important considerations for manufacturers.
The United States is projected to grow at a 7.3% CAGR. Demand spans food applications and pharmaceutical excipients, with FDA-recognized functions and broader specialty-excipient distribution supporting market development.
Japan is expected to register a 6.1% CAGR, supported by established food and pharmaceutical applications. Its designated-additive framework and application-specific use standards make grade selection and regulatory alignment important for suppliers.
Germany is projected to grow at a 5.2% CAGR. Demand is supported by food-grade applications and pharmaceutical excipient requirements, with mature qualification standards favoring specification-led mannitol use.
Regional Context
South Korea and the United Kingdom represent the higher-growth profiled markets, with CAGRs of 8.7% and 8.1%, respectively. Their growth is linked to application demand, established regulatory frameworks, and the need for compliant ingredient and excipient supply.
The United States follows with a 7.3% CAGR, supported by demand across food and pharmaceutical applications. Japan and Germany are projected to grow at 6.1% and 5.2%, respectively, reflecting more established markets where regulatory requirements, formulation qualification, and supplier documentation influence purchasing decisions.
The full report covers North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and the Middle East and Africa, with the United States, United Kingdom, Germany, Japan, and South Korea profiled individually.
Access full Report in PDF Format@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13245
Competitive Landscape
The competitive landscape includes Roquette Frères, SPI Pharma, Cargill, Merck KGaA, B Food Science Co., Ingredion Incorporated, Univar Solutions, Zhejiang Huakang Pharmaceutical Co., Ltd., American International Foods, and Foodchem International. The market includes pharmaceutical excipient specialists, food and polyol manufacturers, and ingredient distributors. Competition is shaped by direct-compression performance, particle engineering, compendial coverage, food-grade availability, technical support, distribution reach, and regulatory documentation.
Recent developments highlight the growing focus on pharmaceutical-grade quality and qualification. In June 2026, SPI Pharma reported completion of a nitrosamine risk assessment and analytical testing program for Mannogem. In April 2026, Mannitab Pharma Specialities received EXCiPACT GMP and GDP certification covering spray-dried and fine-powder mannitol grades. These developments reflect the increasing importance of quality documentation and impurity-risk assessment in pharmaceutical mannitol purchasing.
About Future Market Insights (FMI)
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.
